Cell- and tissue-engineered organ replacements

British Journal of Surgery

Volumn 96, Issue 6, 2009, Pages 565-566

  Birchall, M A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; ANGIOGENESIS; CARTILAGE CELL; CELL DIFFERENTIATION; CLINICAL TRIAL; EMBRYONIC STEM CELL; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; REGENERATIVE MEDICINE; SHORT SURVEY; TISSUE ENGINEERING;

HUMANS; ORGAN TRANSPLANTATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 66749092450     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6666     Document Type: Short Survey

References (9)

1. http://www.unos.org/data/default.asp?displayType=usData.
2. Omori K, Nakamura T, Kanemaru S, Asato R, Yamashita M, Tanaka S et al. Regenerative medicine of the trachea: the first human case. Ann Otol Rhinol Laryngol 2005; 114: 429-433. (Pubitemid 40840073)
3. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006; 367(9518): 1241-1246.
4. Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, Cogan TA et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008; 372(9655): 2023-2030.
5. Kafienah W, Mistry S, Perry MJ, Politopoulou G, Hollander AP. Pharmacological regulation of adult stem cells: chondrogenesis can be induced using a synthetic inhibitor of the retinoic acid receptor. Stem Cells 2007; 25: 2460-2468. (Pubitemid 47582738)
6. Misra SK, Valappil SP, Roy I, Boccaccini AR. Polyhydroxyalkanoate (PHA)/inorganic phase composites for tissue engineering applications. Biomacromolecules 2006; 7: 2249-2258.
7. Grikscheit TC, Siddique A, Ochoa ER, Srinivasan A, Alsberg E, Hodin RA et al. Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg 2004; 240: 748-754. (Pubitemid 39425765)
8. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hämäläinen R et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009; Mar 1. [Epub ahead of print].
9. Lee PH, Kim JW, Bang OY, Ahn YH, Joo IS, Huh K. Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Clin Pharmacol Ther 2008; 83: 723-730.